Title:
ミノドロン酸の新たな結晶形
Document Type and Number:
Japanese Patent JP6705893
Kind Code:
B2
Abstract:
The present invention provides two stable crystalline forms of (1-Hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl) phosphonic acid, designated crystal form X and form Y, as well as methods for their preparation, by which each crystalline polymorph can be individually obtained as a single crystal form.
Inventors:
Stefano Luka Jaffrader
Selena Favroni
Marco Kurzi
Michael chiarucci
Selena Favroni
Marco Kurzi
Michael chiarucci
Application Number:
JP2018516621A
Publication Date:
June 03, 2020
Filing Date:
June 12, 2015
Export Citation:
Assignee:
PolyCrystalLine S.r.l.
PharmaGenerics BV
PharmaGenerics BV
International Classes:
C07F9/6561; A61K31/675; A61P19/08; A61P19/10; A61P25/04; A61P29/00
Domestic Patent References:
| JP62167781A | ||||
| JP54076583A | ||||
| JP61007251A | ||||
| JP50070343A | ||||
| JP2005508378A |
Foreign References:
| WO1994000462A1 | ||||
| CN102875602A | ||||
| CN102153585A | ||||
| CN102268042A | ||||
| CN103910760A |
Attorney, Agent or Firm:
Asamura patent office